Center-Authored Papers

Filters: Author is Rudek, Michelle A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bender Ignacio RA, Lee JY, Rudek MA, Dittmer DP, Ambinder RF, Krown SE.  2015.  A phase 1b/pharmacokinetic trial of PTC299, a novel post-transcriptional VEGF inhibitor, for AIDS-related Kaposi's sarcoma: AIDS Malignancy Consortium trial 059.. Journal of acquired immune deficiency syndromes (1999). Abstract
C
Connolly RM, Li H, Jankowitz RC, Zhang Z, Rudek MA, Jeter SC, Slater SA, Powers P, Wolff AC, Fetting JH et al..  2017.  Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study.. Clinical cancer research : an official journal of the American Association for Cancer Research. 23(11):2691-2701. Abstract
K
Karp JE, Garrett-Mayer EL, Estey EH, Rudek MA, Smith DB, Greer JM, Drye MD, Mackey K, Dorcy KS, Gore SD et al..  2012.  Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.. Haematologica. Abstract